These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25692986)

  • 21. Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy.
    Yabuki K; Sano D; Shiono O; Arai Y; Takahashi H; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
    Head Neck; 2016 Nov; 38(11):1666-1671. PubMed ID: 27143103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
    Gauthé M; Richard-Molard M; Fayard J; Alberini JL; Cacheux W; Lièvre A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):63-70. PubMed ID: 27503193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
    Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
    PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
    Park GC; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Ann Oncol; 2013 Jan; 24(1):208-14. PubMed ID: 23002280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.
    Liu FY; Lai CH; Yang LY; Wang CC; Lin G; Chang CJ; Chang WY; Huang SH; Huang YE; Peng NJ; Hong JH; Chao A; Chou HH; Chang YC; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1812-23. PubMed ID: 27160224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer.
    Chung MK; Jeong HS; Park SG; Jang JY; Son YI; Choi JY; Hyun SH; Park K; Ahn MJ; Ahn YC; Kim HJ; Ko YH; Baek CH
    Clin Cancer Res; 2009 Sep; 15(18):5861-8. PubMed ID: 19737951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
    Schwartz DL; Harris J; Yao M; Rosenthal DI; Opanowski A; Levering A; Ang KK; Trotti AM; Garden AS; Jones CU; Harari P; Foote R; Holland J; Zhang Q; Le QT
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):721-9. PubMed ID: 25752384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
    Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
    Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma.
    Min M; Lin P; Lee MT; Shon IH; Lin M; Forstner D; Bray V; Chicco A; Tieu MT; Fowler A
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1984-94. PubMed ID: 26081941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.
    Chung MK; Jeong HS; Son YI; So YK; Park GY; Choi JY; Hyun SH; Kim HJ; Ko YH; Baek CH
    Ann Surg Oncol; 2009 Nov; 16(11):3111-7. PubMed ID: 19609618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
    Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
    Zhang H; Seikaly H; Nguyen NT; Abele JT; Dziegielewski PT; Harris JR; O'Connell DA
    Oral Oncol; 2016 Jun; 57():6-14. PubMed ID: 27208838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
    Sun Y; Lu P; Yu L
    Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.